“In essence, we have opened the market for growers to grow and produce cannabis flowers that are suitable for every disease”

February 26, 2021

Israeli Agtech startup RCK has completed the first-ever catalog of cannabis strains that covers all the medical indications of the Israeli Medical Cannabis Agency (IMCA).

“The new move opens the path for mass marketing of medical cannabis by growers. The growers will be able to select from RCK’s catalog, which includes dozens of strains. Following the production of each strain, cannabis can be used for treating diseases and other medical and personalized conditions, including cancer, pain, PTSD, autism, and numerous other indications, for treatment during the day and at night,” RCK explains.

In recent years RCK has succeeded in decoding the genetics of cannabis plants and in fully controlling their chemical components. Based on this breakthrough, RCK developed technologies for creating new strains and stable cannabis hybrid seeds of the highest quality. RCK’s strains and seeds meet stringent medical standards and are precisely suited for various medical needs.

“RCK is also offering growers interested in producing a private label the possibility of developing strains based on customer specifications of each grower,” they continue. “Alternatively, the growers can directly purchase from RCK strains developed by the company for exclusive cultivation. This particular group includes strains that are rich in THC (the component with the psychoactive influence), strains that are rich in CBD (the component without the psychoactive influence), and balanced strains (approximately equal amounts of THC and CBD.”